United States to India: Salmeterol Import Trade Route
India has recorded 34 verified shipments of Salmeterol imported from United States, representing a combined trade value of $294.7K USD. This corridor is served by 9 active United States exporters, with an average shipment value of $8.7K USD. The leading United States supplier is SPRING BIO SOLUTION,, which accounts for 40% of total import value with 1 shipments worth $117.8K USD. On the buying side, CIPLA LIMITED is the largest Indian importer with $128.5K USD in purchases. The top 3 suppliers — SPRING BIO SOLUTION,, ESPEE BIOPHARMA FINECHEM LLC, ESPEE BIOPHARMA & FINECHEM LLC — together control 80% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The United States to India Salmeterol corridor is one of India's established pharmaceutical import routes from United States, with 34 shipments documented worth a combined $294.7K USD. The route is dominated by SPRING BIO SOLUTION,, which alone accounts for roughly 40% of all import value, reflecting the consolidated nature of United States's salmeterol export sector.
Across 9 active United States suppliers, the average shipment value stands at $8.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 19.7%, placing it at rank #1 among India's top salmeterol import origins globally.
On the Indian buyer side, key Indian importers include CIPLA LIMITED, GLENMARK PHARMACEUTICALS LIMITED, CIPLA LIMITED. and 3 others. CIPLA LIMITED is the single largest Indian importer with 10 shipments valued at $128.5K USD.
Route Characteristics
- Average transit
